ARCHIVES

M.D. Anderson Investigator Gave Drug To Patients Without IND; NCI Probes Incident, To Make Report

This article is from The Cancer Letter archive.

Vol. 07 No. 29 | July 17, 1981

Download PDF Visit The Full Archive

Related Articles

Bypass Budget Will Call For 15-percent Increase

February 18, 2011

Zometa Can Reduce Risk Of Skeletal-Related Events

August 26, 2011

Troubles of Two Landmark Cancer Drugs, Celebrex and Iressa, Likely to Shape cancer Prevention, FDA Policy. FDA Mulls Withdrawal of Iressa.

January 7, 2005

Clearinghouse Role Broadened By Upton; Asked To Consider All Data In Risk Assessment

November 11, 1977

Funding Opportunities

February 28, 2003

Drug Combination Tested For B.C. Brain Metastases

January 25, 2008